Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy

ConclusionThis case demonstrated a favorable outcome in administering rituximab for NMOSD with disease onset during pregnancy. This description of therapy for disease onset during pregnancy is novel, and adds to the few existing case reports of administering rituximab during pregnancy.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research